US3361306A
(en)
|
1966-03-31 |
1968-01-02 |
Merck & Co Inc |
Aerosol unit dispensing uniform amounts of a medically active ingredient
|
US3565070A
(en)
|
1969-02-28 |
1971-02-23 |
Riker Laboratories Inc |
Inhalation actuable aerosol dispenser
|
FR2224175B1
(es)
|
1973-04-04 |
1978-04-14 |
Isf Spa |
|
US4069819A
(en)
|
1973-04-13 |
1978-01-24 |
Societa Farmaceutici S.P.A. |
Inhalation device
|
IT1017153B
(it)
|
1974-07-15 |
1977-07-20 |
Isf Spa |
Apparecchio per inalazioni
|
NL7606413A
(en)
|
1976-06-14 |
1977-12-16 |
Kowa Co |
Adenosine-5'-phosphoric acid derivs. and their salts - prepd. by acylating adenosine-5'-phosphate and opt. desalting or salt exchanging
|
DE2626792A1
(de)
|
1976-06-15 |
1977-12-29 |
Kowa Co |
Acylderivate von adenosin-5'-monophosphorsaeure, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzung
|
FR2354774A1
(fr)
|
1976-06-15 |
1978-01-13 |
Kowa Co |
Derives de l'acide adenosine-5'-monophosphorique et medicament contenant ces substances
|
SE438261B
(sv)
|
1981-07-08 |
1985-04-15 |
Draco Ab |
Anvendning i dosinhalator av ett perforerat membran
|
US4805811A
(en)
|
1985-03-29 |
1989-02-21 |
Aktiebolaget Draco |
Dosage device
|
SE448277B
(sv)
|
1985-04-12 |
1987-02-09 |
Draco Ab |
Indikeringsanordning vid en doseringsanordning for lekemedel
|
JPS6286363A
(ja)
|
1985-10-11 |
1987-04-20 |
Fuji Photo Film Co Ltd |
ハロゲン化銀カラ−写真感光材料
|
DE3528753A1
(de)
|
1985-08-10 |
1987-02-19 |
Bayer Ag |
Substituierte pyrazolin-5-one
|
US4707540A
(en)
|
1986-10-29 |
1987-11-17 |
Morton Thiokol, Inc. |
Nitramine oxetanes and polyethers formed therefrom
|
US4871758A
(en)
|
1987-03-18 |
1989-10-03 |
Schulman Jerome M |
Pharmacologically active cholinergic compositions, and methods for making same and use thereof in treating disease
|
DE3711345A1
(de)
|
1987-04-03 |
1988-10-20 |
Bayer Ag |
Substituierte propylamine
|
IN167775B
(es)
|
1988-06-24 |
1990-12-22 |
Hoechst India |
|
IT1228459B
(it)
|
1989-02-23 |
1991-06-19 |
Phidea S R L |
Inalatore con svuotamento regolare e completo della capsula.
|
US4955371A
(en)
|
1989-05-08 |
1990-09-11 |
Transtech Scientific, Inc. |
Disposable inhalation activated, aerosol device for pulmonary medicine
|
US5674998A
(en)
|
1989-09-15 |
1997-10-07 |
Gensia Inc. |
C-4' modified adenosine kinase inhibitors
|
DE3932052A1
(de)
|
1989-09-26 |
1991-04-04 |
Basf Ag |
Oxazol- bzw. thiazolcarbonsaeureamide
|
CA2073500C
(en)
|
1990-01-11 |
2008-03-25 |
Phillip Dan Cook |
Compositions and methods for detecting and modulating rna activity and gene expression
|
YU84791A
(sh)
|
1990-05-19 |
1994-06-10 |
Boehringer Ingelheim Kg. |
Biciklicni 1-aza-cikloalkalni
|
MY106399A
(en)
|
1990-07-24 |
1995-05-30 |
Pfizer |
Cephalosporins and homologeus, preparation and pharmaceutical composition
|
FR2669639A1
(fr)
|
1990-11-27 |
1992-05-29 |
Atochem |
Cocatalyseur de polymerisation du propylene a base de silane et de monoether.
|
TW239158B
(es)
|
1991-02-15 |
1995-01-21 |
Lubrizol Corp |
|
JP3230056B2
(ja)
|
1991-07-02 |
2001-11-19 |
インヘイル・インコーポレーテッド |
薬剤のエーロゾル化服用量を形成する装置
|
GB9202791D0
(en)
|
1992-02-11 |
1992-03-25 |
British Bio Technology |
Compounds
|
US5261538A
(en)
|
1992-04-21 |
1993-11-16 |
Glaxo Inc. |
Aerosol testing method
|
US5785049A
(en)
|
1994-09-21 |
1998-07-28 |
Inhale Therapeutic Systems |
Method and apparatus for dispersion of dry powder medicaments
|
DE4232852A1
(de)
|
1992-09-30 |
1994-03-31 |
Bayer Ag |
Imidazolinyl-pyridazine
|
US5388572A
(en)
|
1993-10-26 |
1995-02-14 |
Tenax Corporation (A Connecticut Corp.) |
Dry powder medicament inhalator having an inhalation-activated piston to aerosolize dose and deliver same
|
US5446137B1
(en)
|
1993-12-09 |
1998-10-06 |
Behringwerke Ag |
Oligonucleotides containing 4'-substituted nucleotides
|
DE69522494T2
(de)
|
1994-04-14 |
2002-04-25 |
Canon K.K., Tokio/Tokyo |
Flüssigkristallzusammensetzung, Anzeigevorrichtung und Verfahren diese verwendend
|
US5522385A
(en)
|
1994-09-27 |
1996-06-04 |
Aradigm Corporation |
Dynamic particle size control for aerosolized drug delivery
|
US5681940A
(en)
|
1994-11-02 |
1997-10-28 |
Icn Pharmaceuticals |
Sugar modified nucleosides and oligonucleotides
|
US5544647A
(en)
|
1994-11-29 |
1996-08-13 |
Iep Group, Inc. |
Metered dose inhalator
|
US5622163A
(en)
|
1994-11-29 |
1997-04-22 |
Iep Group, Inc. |
Counter for fluid dispensers
|
JP3822925B2
(ja)
|
1995-07-18 |
2006-09-20 |
興和株式会社 |
2’−3’−ジ−o−アシルatpの製造法
|
JPH09328497A
(ja)
|
1996-04-12 |
1997-12-22 |
Yamasa Shoyu Co Ltd |
4’−フルオロメチルヌクレオシド
|
CN1233254A
(zh)
|
1996-10-16 |
1999-10-27 |
Icn药品公司 |
嘌呤l-核苷、其类似物及其用途
|
EP1000075A4
(en)
|
1997-06-30 |
2001-09-05 |
Icn Pharmaceuticals |
PROCESS FOR PRODUCING TIAZOFURINE AND OTHER C-NUCLEOSIDES
|
EP2341058A3
(en)
|
1997-09-12 |
2011-11-23 |
Exiqon A/S |
Oligonucleotide Analogues
|
AU1608399A
(en)
|
1997-11-26 |
1999-06-15 |
Axys Pharmaceuticals, Inc. |
Substituted amidinoaryl derivatives and their use as anticoagulants
|
US6150379A
(en)
|
1997-11-26 |
2000-11-21 |
Axys Pharmaceuticals, Inc. |
Compounds and compositions as anticoagulants
|
US5972099A
(en)
|
1997-12-17 |
1999-10-26 |
Bayer Corporation |
Process for preparing organic pigment compositions
|
PE20000354A1
(es)
|
1998-04-03 |
2000-05-20 |
Advanced Medicine Inc |
Nuevos compuestos y usos anestesicos locales
|
WO1999061583A2
(en)
|
1998-05-28 |
1999-12-02 |
Incara Pharmaceuticals Corp. |
Carbohydrate-based scaffold compounds, combinatorial libraries and methods for their construction
|
EP1094805A4
(en)
|
1998-07-03 |
2002-08-28 |
Millennium Pharm Inc |
ALICYCLIC COMPOUNDS WITH SUBSTITUTED OXYGEN ATOM, AND THEIR PREPARATION METHOD
|
AU1933800A
(en)
|
1998-12-02 |
2000-06-19 |
Princeton University |
Compositions and methods for regulating bacterial pathogenesis
|
US6432975B1
(en)
|
1998-12-11 |
2002-08-13 |
Targacept, Inc. |
Pharmaceutical compositions and methods for use
|
US6116234A
(en)
|
1999-02-01 |
2000-09-12 |
Iep Pharmaceutical Devices Inc. |
Metered dose inhaler agitator
|
EP1046631A1
(en)
|
1999-04-19 |
2000-10-25 |
Rolic AG |
Liquid crystalline compounds
|
GB9908934D0
(en)
|
1999-04-19 |
1999-06-16 |
Rolic Ag |
Liquid crystalline compounds
|
US7053207B2
(en)
|
1999-05-04 |
2006-05-30 |
Exiqon A/S |
L-ribo-LNA analogues
|
AUPQ105499A0
(en)
|
1999-06-18 |
1999-07-08 |
Biota Scientific Management Pty Ltd |
Antiviral agents
|
AU5780800A
(en)
|
1999-06-29 |
2001-01-31 |
Uab Research Foundation, The |
Methods of treating fungal infections with inhibitors of nad synthetase enzyme
|
DE19934799B4
(de)
|
1999-07-28 |
2008-01-24 |
Az Electronic Materials (Germany) Gmbh |
Chiral-smektische Flüssigkristallmischung und ihre Verwendung in Aktivmatrix-Displays mit hohen Kontrastwerten
|
CA2381008A1
(en)
|
1999-08-04 |
2001-02-15 |
Millennium Pharmaceuticals, Inc. |
Melanocortin-4 receptor binding compounds and methods of use thereof
|
DE19939910A1
(de)
|
1999-08-23 |
2001-03-01 |
Morphochem Ag |
Neue Verbindungen, die Tryptase-Aktivität hemmen
|
EP1214332A1
(en)
|
1999-09-17 |
2002-06-19 |
Amersham Biosciences Corp. |
Charge-modified nucleic acid terminators
|
AU7315700A
(en)
|
1999-09-20 |
2001-04-24 |
Takeda Chemical Industries Ltd. |
Melanin concentrating hormone antagonist
|
US6514964B1
(en)
|
1999-09-27 |
2003-02-04 |
Amgen Inc. |
Fused cycloheptane and fused azacycloheptane compounds and their methods of use
|
GB9930557D0
(en)
|
1999-12-23 |
2000-02-16 |
Rolic Ag |
Optically active materials
|
DK1259485T3
(da)
|
2000-02-29 |
2006-04-10 |
Millennium Pharm Inc |
Benzamider og beslægtede inhibitorer for faktor Xa
|
US20090124690A1
(en)
|
2000-04-03 |
2009-05-14 |
Alberte Randall S |
Generation of Combinatorial Synthetic Libraries and Screening for Novel Proadhesins and Nonadhesins
|
US6727267B2
(en)
|
2000-04-05 |
2004-04-27 |
Tularik Inc. |
NS5B HVC polymerase inhibitors
|
US6696081B2
(en)
|
2000-06-09 |
2004-02-24 |
Duke University |
Carbohydrate based lipid compositions and supramolecular structures comprising same
|
EP1170353B1
(en)
|
2000-07-06 |
2005-11-02 |
Fuji Photo Film Co., Ltd. |
Liquid crystal composition comprising liquid crystal molecules and aligment promoter
|
EP1301074A2
(en)
|
2000-07-14 |
2003-04-16 |
The UAB Research Foundation |
Uses for nad synthetase inhibitors
|
AU2001279955A1
(en)
|
2000-08-18 |
2002-03-04 |
Sterix Limited |
2-substituted estradiol derivative for inhibiting superoxid dismutase
|
AU2001294865A1
(en)
|
2000-09-30 |
2002-04-15 |
Loctite |
Low shrinkage thermosetting resin compositions and methods of use therefor
|
NZ526003A
(en)
|
2000-10-20 |
2005-09-30 |
Biocryst Pharm Inc |
Biaryl compounds as serine protease inhibitors
|
AUPR105700A0
(en)
|
2000-10-27 |
2000-11-23 |
Monash University |
Process for preparation of bicyclic and polycyclic molecules
|
WO2002039987A2
(en)
|
2000-11-14 |
2002-05-23 |
Neurosearch A/S |
Use of malaria parasite anion channel blockers for treating malaria
|
AUPR213700A0
(en)
|
2000-12-18 |
2001-01-25 |
Biota Scientific Management Pty Ltd |
Antiviral agents
|
DE10064823A1
(de)
|
2000-12-22 |
2002-06-27 |
Knoll Ag |
Integrinrezeptorliganden
|
WO2002062766A2
(en)
|
2001-02-07 |
2002-08-15 |
Millennium Pharmaceuticals, Inc. |
Melanocortin-4 receptor binding compounds and methods of use thereof
|
JP2002326996A
(ja)
|
2001-03-02 |
2002-11-15 |
Toray Ind Inc |
光学活性体の製造法
|
JP4161291B2
(ja)
|
2001-03-02 |
2008-10-08 |
東レ・ファインケミカル株式会社 |
光学活性体の製造法
|
ATE438615T1
(de)
|
2001-04-06 |
2009-08-15 |
Biocryst Pharm Inc |
Biarylverbindungen als serinproteaseinhibitoren
|
EP2415486B1
(en)
|
2001-05-18 |
2017-02-22 |
Sirna Therapeutics, Inc. |
Conjugates and compositions for cellular delivery
|
US20030175950A1
(en)
|
2001-05-29 |
2003-09-18 |
Mcswiggen James A. |
RNA interference mediated inhibition of HIV gene expression using short interfering RNA
|
US20030170891A1
(en)
|
2001-06-06 |
2003-09-11 |
Mcswiggen James A. |
RNA interference mediated inhibition of epidermal growth factor receptor gene expression using short interfering nucleic acid (siNA)
|
GB0114286D0
(en)
|
2001-06-12 |
2001-08-01 |
Hoffmann La Roche |
Nucleoside Derivatives
|
CA2458926A1
(en)
|
2001-09-13 |
2003-03-13 |
Genesoft Pharmaceuticals, Inc. |
Methods of treating infection by drug resistant bacteria
|
WO2003039523A2
(en)
|
2001-11-05 |
2003-05-15 |
Exiqon A/S |
OLIGONUCLEOTIDES MODIFIED WITH NOVEL α-L-RNA ANALOGUES
|
EP1446115B1
(en)
|
2001-11-13 |
2008-02-27 |
Merck Frosst Canada Ltd. |
Cyanoalkylamino derivatives as protease inhibitors
|
US7169814B2
(en)
|
2001-12-11 |
2007-01-30 |
The Board Of Trustees Of The Leland Stanford Junior University |
Guanidinium transport reagents and conjugates
|
JP2003246770A
(ja)
|
2002-02-25 |
2003-09-02 |
Toray Ind Inc |
光学活性体の製造法
|
TW200403058A
(en)
|
2002-04-19 |
2004-03-01 |
Bristol Myers Squibb Co |
Heterocyclo inhibitors of potassium channel function
|
US6869904B2
(en)
|
2002-04-24 |
2005-03-22 |
Symyx Technologies, Inc. |
Bridged bi-aromatic ligands, catalysts, processes for polymerizing and polymers therefrom
|
CA2483253A1
(en)
|
2002-04-24 |
2003-11-06 |
Takeda Pharmaceutical Company Limited |
Use of compounds having ccr antagonism
|
PT1523489E
(pt)
|
2002-06-28 |
2014-06-24 |
Centre Nat Rech Scient |
Profármacos de nucleósido modificado em 2' e 3' para tratamento de infecções por flaviridae
|
WO2004007472A1
(ja)
|
2002-07-10 |
2004-01-22 |
Ono Pharmaceutical Co., Ltd. |
Ccr4アンタゴニストおよびその医薬用途
|
AU2003259735A1
(en)
|
2002-08-08 |
2004-02-25 |
Sirna Therapeutics, Inc. |
Small-mer compositions and methods of use
|
AU2003274652A1
(en)
|
2002-10-23 |
2004-05-13 |
Obetherapy Biotechnology |
Compounds, compositions and methods for modulating fat metabolism
|
US20040229840A1
(en)
|
2002-10-29 |
2004-11-18 |
Balkrishen Bhat |
Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase
|
US20040146941A1
(en)
|
2002-11-04 |
2004-07-29 |
Biliang Zhang |
Chemical encoding technology for combinatorial synthesis
|
US7329658B2
(en)
|
2003-02-06 |
2008-02-12 |
Pfizer Inc |
Cannabinoid receptor ligands and uses thereof
|
US7176210B2
(en)
|
2003-02-10 |
2007-02-13 |
Pfizer Inc. |
Cannabinoid receptor ligands and uses thereof
|
TWI344955B
(en)
|
2003-03-14 |
2011-07-11 |
Ono Pharmaceutical Co |
Heterocyclic rinf having nitrogen atom derivatives and medicament containing the derivatives as active ingredient
|
US7135469B2
(en)
|
2003-03-18 |
2006-11-14 |
Bristol Myers Squibb, Co. |
Linear chain substituted monocyclic and bicyclic derivatives as factor Xa inhibitors
|
GB0306430D0
(en)
|
2003-03-20 |
2003-04-23 |
Bp Chem Int Ltd |
Polymerisation and oligomerisation catalysts
|
ES2423800T3
(es)
|
2003-03-28 |
2013-09-24 |
Novartis Vaccines And Diagnostics, Inc. |
Uso de compuestos orgánicos para la inmunopotenciación
|
EP1613261A4
(en)
|
2003-04-09 |
2011-01-26 |
Novo Nordisk As |
INTRA-CELLULAR FORMATION OF PEPTIDE CONJUGATES
|
JP2004315613A
(ja)
|
2003-04-14 |
2004-11-11 |
Fuji Photo Film Co Ltd |
セルロースアシレートフィルム、その製造方法、偏光板保護膜、液晶表示装置、及びハロゲン化銀写真感光材料
|
US7268133B2
(en)
|
2003-04-23 |
2007-09-11 |
Pfizer, Inc. Patent Department |
Cannabinoid receptor ligands and uses thereof
|
BRPI0410348A
(pt)
|
2003-05-14 |
2006-05-30 |
Torreypines Therapeutics Inc |
compostos e usos dos mesmos na modulação de amilóide-beta
|
US20040229839A1
(en)
|
2003-05-14 |
2004-11-18 |
Biocryst Pharmaceuticals, Inc. |
Substituted nucleosides, preparation thereof and use as inhibitors of RNA viral polymerases
|
WO2005020885A2
(en)
|
2003-05-21 |
2005-03-10 |
Isis Pharmaceuticals, Inc. |
Compositions and methods for the treatment of severe acute respiratory syndrome (sars)
|
WO2004106356A1
(en)
|
2003-05-27 |
2004-12-09 |
Syddansk Universitet |
Functionalized nucleotide derivatives
|
WO2005021568A2
(en)
|
2003-08-27 |
2005-03-10 |
Biota, Inc. |
Novel tricyclic nucleosides or nucleotides as therapeutic agents
|
EP1661889A4
(en)
|
2003-09-05 |
2009-08-05 |
Ono Pharmaceutical Co |
ANTAGONIST OF THE CHEMOKINE RECEPTOR AND ITS USE FOR MEDICAL PURPOSES
|
WO2005025515A2
(en)
|
2003-09-12 |
2005-03-24 |
California Institute Of Technology |
Proteasome pathway inhibitors and related methods
|
JP4231379B2
(ja)
|
2003-10-15 |
2009-02-25 |
富士フイルム株式会社 |
潤滑剤組成物
|
JPWO2005040135A1
(ja)
|
2003-10-24 |
2007-03-08 |
小野薬品工業株式会社 |
抗ストレス薬およびその医薬用途
|
EP1692110A1
(en)
|
2003-12-10 |
2006-08-23 |
MERCK PATENT GmbH |
Diacylhydrazine derivatives
|
WO2005093476A1
(en)
|
2004-03-25 |
2005-10-06 |
Fuji Photo Film Co., Ltd. |
Transparent film and optical compensatory film, polarizing plate and liquid-crystal display device employing it
|
JP2007530470A
(ja)
|
2004-03-25 |
2007-11-01 |
メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフトング |
液晶化合物、液晶媒体および液晶ディスプレイ
|
US7306631B2
(en)
|
2004-03-30 |
2007-12-11 |
The Procter & Gamble Company |
Keratin dyeing compounds, keratin dyeing compositions containing them, and use thereof
|
EP1593713A1
(en)
|
2004-05-04 |
2005-11-09 |
Rolic AG |
Polymerizable dichromophoric dichroic azo dyes
|
GB0410604D0
(en)
|
2004-05-12 |
2004-06-16 |
Bp Chem Int Ltd |
Ethylene copolymers
|
BRPI0512049A
(pt)
*
|
2004-06-14 |
2008-02-06 |
Anacor Pharmaceuticals Inc |
usos antivirais de complexos de ácido borìnico
|
US8039674B2
(en)
|
2004-06-23 |
2011-10-18 |
Ono Pharmaceutical Co., Ltd. |
Compound having S1P receptor binding potency and use thereof
|
WO2006006490A1
(ja)
|
2004-07-08 |
2006-01-19 |
Ono Pharmaceutical Co., Ltd. |
スピロ化合物
|
GB0415879D0
(en)
|
2004-07-15 |
2004-08-18 |
Bp Chem Int Ltd |
Polymerisation catalyst
|
GB0418022D0
(en)
|
2004-08-12 |
2004-09-15 |
Bp Chem Int Ltd |
Polymerisation and oligomerisation catalyst
|
GB0420396D0
(en)
|
2004-09-14 |
2004-10-13 |
Bp Chem Int Ltd |
Polyolefins
|
WO2006038594A1
(ja)
|
2004-10-04 |
2006-04-13 |
Ono Pharmaceutical Co., Ltd. |
N型カルシウムチャネル阻害薬
|
GB0424422D0
(en)
|
2004-11-04 |
2004-12-08 |
Bp Chem Int Ltd |
Polymerisation catalysts
|
JP4429149B2
(ja)
|
2004-11-26 |
2010-03-10 |
キヤノン株式会社 |
フルオレン化合物及び有機発光素子
|
GB2436261B
(en)
|
2004-12-11 |
2010-06-09 |
Merck Patent Gmbh |
Liquid crystal compounds,liquid crystal medium and liquid crystal display
|
WO2006066074A2
(en)
|
2004-12-16 |
2006-06-22 |
The Regents Of The University Of California |
Lung-targeted drugs
|
WO2006063717A2
(en)
|
2004-12-16 |
2006-06-22 |
Febit Biotech Gmbh |
Polymerase-independent analysis of the sequence of polynucleotides
|
JP4749000B2
(ja)
|
2005-02-22 |
2011-08-17 |
富士フイルム株式会社 |
グリース組成物
|
US7622240B2
(en)
|
2005-02-28 |
2009-11-24 |
International Business Machines Corporation |
Low blur molecular resist
|
US8802840B2
(en)
|
2005-03-08 |
2014-08-12 |
Biota Scientific Management Pty Ltd. |
Bicyclic nucleosides and nucleotides as therapeutic agents
|
DE602006016928D1
(de)
|
2005-03-15 |
2010-10-28 |
Fujifilm Corp |
Oberflächenbehandlungsverfahren unter verwendung einer scheibenartigen verbindung, (schmier)zusammensetzung zur oberflächenbehandlung und oberflächenbehandelter gegenstand
|
CA2610854A1
(en)
|
2005-03-30 |
2006-10-05 |
Sirtris Pharmaceuticals, Inc. |
Nicotinamide riboside and analogues thereof
|
US20090156545A1
(en)
|
2005-04-01 |
2009-06-18 |
Hostetler Karl Y |
Substituted Phosphate Esters of Nucleoside Phosphonates
|
US20070003608A1
(en)
|
2005-04-08 |
2007-01-04 |
Almond Merrick R |
Compounds, compositions and methods for the treatment of viral infections and other medical disorders
|
WO2006119800A1
(en)
|
2005-05-09 |
2006-11-16 |
Technische Universität Braunschweig |
Light emitting compound for electroluminescent applications
|
US7576205B2
(en)
|
2005-06-13 |
2009-08-18 |
Agency For Science, Technology & Research |
Detectable threading intercalator
|
WO2007007588A1
(ja)
|
2005-07-08 |
2007-01-18 |
Ono Pharmaceutical Co., Ltd. |
平面性を有する環状基を母核とする化合物
|
WO2007011759A2
(en)
|
2005-07-15 |
2007-01-25 |
Kalypsys, Inc. |
Inhibitors of mitotic kinesin
|
JP2007056213A
(ja)
|
2005-08-26 |
2007-03-08 |
Fujifilm Corp |
焼結含油軸受油用組成物、並びにそれを用いた軸受け装置及び摺動部材
|
DE102005043165A1
(de)
|
2005-09-12 |
2007-03-22 |
Merck Patent Gmbh |
Metallkomplexe
|
US20070219192A1
(en)
|
2005-11-02 |
2007-09-20 |
Xiangping Qian |
Certain chemical entities, compositions, and methods
|
WO2007056170A2
(en)
|
2005-11-02 |
2007-05-18 |
Bayer Healthcare Ag |
Pyrrolo[2,1-f] [1,2,4] triazin-4-ylamines igf-1r kinase inhibitors for the treatment of cancer and other hyperproliferative diseases
|
AU2006330924B2
(en)
|
2005-12-21 |
2012-03-15 |
Abbvie Inc. |
Anti-viral compounds
|
TW200738709A
(en)
|
2006-01-19 |
2007-10-16 |
Osi Pharm Inc |
Fused heterobicyclic kinase inhibitors
|
DE602007008837D1
(de)
|
2006-02-14 |
2010-10-14 |
Vertex Pharma |
Als protein-kinase-inhibitoren nutzbare dyhydrodiazepine
|
CN101460463A
(zh)
|
2006-03-29 |
2009-06-17 |
先灵公司 |
可作为凝血酶受体拮抗剂的单环和双环喜巴辛衍生物
|
JP2009534454A
(ja)
|
2006-04-25 |
2009-09-24 |
アステックス、セラピューティックス、リミテッド |
医薬化合物
|
JP5320284B2
(ja)
|
2006-05-03 |
2013-10-23 |
キメリクス,インコーポレーテッド |
抗ウイルス性または抗増殖性のホスホネート、ヌクレオシドホスホネートおよびヌクレオシドホスフェートの代謝安定性アルコキシアルキルエステル
|
WO2008001195A2
(en)
|
2006-06-27 |
2008-01-03 |
Glenmark Pharmaceuticals S.A. |
Novel processes for the preparation of dpp iv inhibitors
|
JP2008007634A
(ja)
|
2006-06-29 |
2008-01-17 |
Fujifilm Corp |
潤滑剤組成物
|
JP2009544625A
(ja)
|
2006-07-20 |
2009-12-17 |
メーメット・カーラマン |
Rhoキナーゼのベンゾチオフェン阻害剤
|
GB0614947D0
(en)
|
2006-07-27 |
2006-09-06 |
Isis Innovation |
Epitope reduction therapy
|
PE20080906A1
(es)
|
2006-08-17 |
2008-07-05 |
Kemia Inc |
Derivados heteroarilo como inhibidores de citocina
|
WO2008024364A2
(en)
|
2006-08-22 |
2008-02-28 |
Redpoint Bio Corporation |
Heterocyclic compounds as sweetener enhancers
|
US20080261913A1
(en)
|
2006-12-28 |
2008-10-23 |
Idenix Pharmaceuticals, Inc. |
Compounds and pharmaceutical compositions for the treatment of liver disorders
|
NZ598927A
(en)
|
2007-01-12 |
2013-09-27 |
Biocryst Pharm Inc |
Antiviral nucleoside analogs
|
US20090016990A1
(en)
|
2007-01-24 |
2009-01-15 |
Alberte Randall S |
Antimicrobial Compositions
|
KR20100014878A
(ko)
|
2007-01-31 |
2010-02-11 |
앨리오스 바이오파마 인크. |
2-5a 유도체, 및 항암제, 항바이러스제 및 항기생충제로서 이의 용도
|
CA2680312A1
(en)
|
2007-03-07 |
2008-09-12 |
Alantos Pharmaceuticals Holding, Inc. |
Metalloprotease inhibitors containing a heterocyclic moiety
|
US8088566B2
(en)
|
2007-03-26 |
2012-01-03 |
Fujifilm Corporation |
Surface-treating agent for pattern formation and pattern-forming method using the surface-treating agent
|
WO2008117047A1
(en)
|
2007-03-27 |
2008-10-02 |
Astrazeneca Ab |
Pyrazolo[3, 4-d]pyrimidine derivatives as antibacterial compounds
|
US7956020B2
(en)
|
2007-03-29 |
2011-06-07 |
Fujifilm Corporation |
Lubricant composition, mechanical element, and method for producing triazine derivatives
|
US8088940B2
(en)
|
2007-03-30 |
2012-01-03 |
Momentive Performance Materials Inc. |
Hydrolyzable silanes of low VOC-generating potential and resinous compositions containing same
|
JP2010525063A
(ja)
|
2007-04-27 |
2010-07-22 |
キメリクス,インコーポレイテッド |
ヌクレオシドホスホナートが投与された被験者における腎毒性を減少させる方法
|
ES2393038T3
(es)
|
2007-05-10 |
2012-12-18 |
Biocryst Pharmaceuticals, Inc. |
Compuestos de tretrahidrofuro[3,4-D]dioxolano para su utlilización en el tratamiento de las infecciones víricas y del cáncer
|
EP2173740A4
(en)
|
2007-06-14 |
2011-09-07 |
Osta Biotechnologies |
INHIBITORS OF HEMOXYGENASE AND THEIR USE IN THE TREATMENT OF CANCER AND DISEASES OF THE CENTRAL NERVOUS SYSTEM
|
US20110319459A1
(en)
|
2007-06-14 |
2011-12-29 |
Osta Biotechnologies |
Compounds and Methods for Treating Cancer and Diseases of the Central Nervous System
|
GB0712494D0
(en)
|
2007-06-27 |
2007-08-08 |
Isis Innovation |
Substrate reduction therapy
|
CN100532388C
(zh)
|
2007-07-16 |
2009-08-26 |
郑州大学 |
2’-氟-4’-取代-核苷类似物、其制备方法及应用
|
JP5604872B2
(ja)
|
2007-07-19 |
2014-10-15 |
コニカミノルタ株式会社 |
セルロースエステルフィルム
|
WO2009011228A1
(ja)
|
2007-07-19 |
2009-01-22 |
Konica Minolta Opto, Inc. |
セルロースエステルフィルム、セルロースエステルフィルムの製造方法、それを用いた偏光板、及び液晶表示装置
|
US9340506B2
(en)
|
2007-10-08 |
2016-05-17 |
Advinus Therapeutics Limited |
Acetamide derivatives as glucokinase activators, their process and medicinal applications
|
US20090318380A1
(en)
|
2007-11-20 |
2009-12-24 |
Pharmasset, Inc. |
2',4'-substituted nucleosides as antiviral agents
|
AR069740A1
(es)
|
2007-11-29 |
2010-02-17 |
Metabasis Therapeutics Inc |
Compuestos nucleosidos antivirales
|
AU2008335031B2
(en)
|
2007-12-13 |
2013-11-28 |
Vertex Pharmaceuticals Incorporated |
Modulators of cystic fibrosis transmembrane conductance regulator
|
WO2009086201A1
(en)
|
2007-12-21 |
2009-07-09 |
Alios Biopharma, Inc. |
2-5a analogs and their use as anti-cancer, anti-viral and anti- paras iti c agents
|
US20090176732A1
(en)
|
2007-12-21 |
2009-07-09 |
Alios Biopharma Inc. |
Protected nucleotide analogs
|
TW200942243A
(en)
|
2008-03-05 |
2009-10-16 |
Biocryst Pharm Inc |
Antiviral therapeutic agents
|
EP2098226A1
(de)
|
2008-03-06 |
2009-09-09 |
Forschungsverbund Berlin e.V. |
AKAP-PKA-Interaktionshemmer zur Anwendung in der Behandlung von Herzkrankheiten
|
SI2937350T1
(en)
|
2008-04-23 |
2018-05-31 |
Gilead Sciences, Inc. |
1'-SUBSTITUTED CARBON-NUCLEOUS ANALOGS FOR ANTIVIRUSAL TREATMENT
|
WO2010036407A2
(en)
|
2008-05-15 |
2010-04-01 |
Biocryst Pharmaceuticals, Inc. |
Antiviral nucleoside analogs
|
AU2009257815B2
(en)
|
2008-05-27 |
2014-05-29 |
Trilink Biotechnologies |
Chemically modified nucleoside 5'-triphosphates for thermally initiated amplification of nucleic acid
|
US8173621B2
(en)
|
2008-06-11 |
2012-05-08 |
Gilead Pharmasset Llc |
Nucleoside cyclicphosphates
|
US7910019B2
(en)
|
2008-06-27 |
2011-03-22 |
Transitions Optical, Inc. |
Mesogen containing compounds
|
US7910020B2
(en)
|
2008-06-27 |
2011-03-22 |
Transitions Optical, Inc. |
Liquid crystal compositions comprising mesogen containing compounds
|
US8628685B2
(en)
|
2008-06-27 |
2014-01-14 |
Transitions Optical, Inc |
Mesogen-containing compounds
|
US7803285B2
(en)
|
2008-07-01 |
2010-09-28 |
Gentex Corporation |
Liquid crystal display device and associated liquid crystal media for use in the same
|
EP2313102A2
(en)
|
2008-07-03 |
2011-04-27 |
Biota Scientific Management |
Bycyclic nucleosides and nucleotides as therapeutic agents
|
GB0812297D0
(en)
|
2008-07-04 |
2008-08-13 |
Lucite Int Uk Ltd |
Novel carbonylation ligand sand thier use of in the carbonylation of ethylenically unsaturated compounds
|
UY31982A
(es)
|
2008-07-16 |
2010-02-26 |
Boehringer Ingelheim Int |
Derivados de 1,2-dihidropiridin-3-carboxamidas n-sustituidas
|
GB0815968D0
(en)
|
2008-09-03 |
2008-10-08 |
Angeletti P Ist Richerche Bio |
Antiviral agents
|
JP5295692B2
(ja)
|
2008-09-10 |
2013-09-18 |
豊和工業株式会社 |
自動開閉防音サッシ
|
EP3587434A1
(en)
|
2008-09-23 |
2020-01-01 |
Alnylam Pharmaceuticals Inc. |
Chemical modifications of monomers and oligonucleotides with click components for conjugation with ligands
|
US20100096603A1
(en)
|
2008-10-20 |
2010-04-22 |
Nitto Denko Corporation |
Optical devices responsive to near infrared laser and methods of modulating light
|
AR074231A1
(es)
|
2008-11-27 |
2010-12-29 |
Boehringer Ingelheim Int |
Derivados de 6, 7, 8, 9-tetrahidro-5h-1, 4, 7, 10a-tetraaza-ciclohept[f]indeno, composiciones farmacéuticas que contienen estos compuestos, su uso en el agonismo del receptor 5-ht2c y procesos para prepararlos.
|
WO2010073126A2
(en)
|
2008-12-22 |
2010-07-01 |
The Governors Of The University Of Alberta |
Compounds useful in delivering anti-neoplastic therapy and diagnostic imaging to hypoxic cells and methods of use thereof
|
GB0900914D0
(en)
|
2009-01-20 |
2009-03-04 |
Angeletti P Ist Richerche Bio |
Antiviral agents
|
US9040718B2
(en)
|
2009-01-22 |
2015-05-26 |
The University Of Rochester |
Hybrid host materials for electrophosphorescent devices
|
KR20100087540A
(ko)
|
2009-01-28 |
2010-08-05 |
삼성전자주식회사 |
잉크젯 기록용 잉크 조성물
|
EP2408306A4
(en)
|
2009-03-20 |
2012-11-07 |
Alios Biopharma Inc |
SUBSTITUTED NUCLEOSIDE AND NUCLEOTIDE ANALOGUES
|
US20100240604A1
(en)
|
2009-03-20 |
2010-09-23 |
Alios Biopharma, Inc. |
Protected nucleotide analogs
|
EP2264169A1
(en)
|
2009-06-15 |
2010-12-22 |
Qiagen GmbH |
Modified siNA
|
US20110212994A1
(en)
|
2009-06-26 |
2011-09-01 |
Brian Clem |
Small Molecule Choline Kinase Inhibitors, Screening Assays, and Methods for Safe and Effective Treatment of Neoplastic Disorders
|
WO2011005860A2
(en)
|
2009-07-07 |
2011-01-13 |
Alnylam Pharmaceuticals, Inc. |
5' phosphate mimics
|
CN102473843A
(zh)
|
2009-08-04 |
2012-05-23 |
三菱化学株式会社 |
光电转换元件及使用该元件的太阳能电池
|
EP2462138B1
(en)
|
2009-08-05 |
2014-09-24 |
Versitech Limited |
Antiviral compounds and methods of making
|
CN102625708A
(zh)
|
2009-09-09 |
2012-08-01 |
阿维拉制药公司 |
Pi3激酶抑制剂及其用途
|
US20120189670A1
(en)
|
2009-09-14 |
2012-07-26 |
Kirkpatrick D Lynn |
Pharmaceutical compositions and formulations including inhibitors of the pleckstrin homology domain and methods for using same
|
US10023600B2
(en)
|
2009-09-21 |
2018-07-17 |
Gilead Sciences, Inc. |
Processes and intermediates for the preparation of 1′-substituted carba-nucleoside analogs
|
RS55699B1
(sr)
|
2009-09-21 |
2017-07-31 |
Gilead Sciences |
2' -fluoro supstituisani karba-nukleozidni analozi zaantiviralno lečenje
|
US8455451B2
(en)
|
2009-09-21 |
2013-06-04 |
Gilead Sciences, Inc. |
2'-fluoro substituted carba-nucleoside analogs for antiviral treatment
|
WO2011036557A1
(en)
|
2009-09-22 |
2011-03-31 |
The University Of British Columbia |
Compositions and methods for enhancing cellular uptake and intracellular delivery of lipid particles
|
WO2011038207A1
(en)
|
2009-09-25 |
2011-03-31 |
Metabasis Therapeutics, Inc. |
Phosphorus-containing thyroid hormone receptor agonists and methods of use
|
DE102010035730A1
(de)
|
2009-09-28 |
2011-04-07 |
Merck Patent Gmbh |
Polymerisierbare Verbindungen und ihre Verwendung in Flüssigkristallanzeigen
|
WO2011057214A2
(en)
|
2009-11-09 |
2011-05-12 |
Neurogenetic Pharmaceuticals, Inc. |
Gamma-secretase modulatory compounds, methods for identifying same, and uses therefor
|
CN102000103B
(zh)
|
2009-12-21 |
2011-12-21 |
郑州大学 |
2’-氟-4’-叠氮-核苷类似物或其盐的药物应用
|
AR079980A1
(es)
|
2010-01-13 |
2012-03-07 |
Sanofi Aventis |
Derivados de oxazolopirimidina sustituida en 2,5,7
|
US9198972B2
(en)
|
2010-01-28 |
2015-12-01 |
Alnylam Pharmaceuticals, Inc. |
Monomers and oligonucleotides comprising cycloaddition adduct(s)
|
WO2011094890A1
(en)
|
2010-02-02 |
2011-08-11 |
Argusina Inc. |
Phenylalanine derivatives and their use as non-peptide glp-1 receptor modulators
|
CA2791914C
(en)
|
2010-03-05 |
2019-01-15 |
Karyopharm Therapeutics, Inc. |
Nuclear transport modulators and uses thereof
|
WO2011119869A1
(en)
|
2010-03-24 |
2011-09-29 |
Medical University Of South Carolina |
Compositions and methods for the treatment of degenerative diseases
|
WO2011146401A1
(en)
|
2010-05-17 |
2011-11-24 |
Intermune, Inc. |
Novel inhibitors of hepatitis c virus replication
|
FR2960235B1
(fr)
|
2010-05-18 |
2013-11-01 |
Inst Francais Du Petrole |
Procede d'oligomerisation des olefines utilisant une composition comprenant un complexe organometallique contenant un ligand alcoxy fonctionnalise par un hetero-atome.
|
FR2960234B1
(fr)
|
2010-05-18 |
2013-11-01 |
Inst Francais Du Petrole |
Procede de dimerisation de l'ethylene en butene-1 utilisant une composition comprenant un complexe a base de titane et un ligand alcoxy fonctionnalise par un hetero-atome.
|
TW201201815A
(en)
|
2010-05-28 |
2012-01-16 |
Gilead Sciences Inc |
1'-substituted-carba-nucleoside prodrugs for antiviral treatment
|
WO2011156632A2
(en)
|
2010-06-09 |
2011-12-15 |
Georgetown University |
Compositions and methods of treatment for tumors in the nervous system
|
US8614021B2
(en)
|
2010-06-10 |
2013-12-24 |
The United States Of America As Represented By The Secretary Of The Army |
Agents for enhanced charge transport across microbial membranes
|
EP2805960A1
(en)
|
2010-07-19 |
2014-11-26 |
Gilead Sciences, Inc. |
Methods for the preparation of diasteromerically pure phosphoramidate prodrugs
|
SG186830A1
(en)
|
2010-07-22 |
2013-02-28 |
Gilead Sciences Inc |
Methods and compounds for treating paramyxoviridae virus infections
|
CN102351931B
(zh)
|
2010-09-07 |
2014-01-22 |
河南省科学院高新技术研究中心 |
嘧啶核苷衍生物、合成方法及其在制备抗肿瘤、抗病毒药物中的应用
|
TW201305185A
(zh)
|
2010-09-13 |
2013-02-01 |
Gilead Sciences Inc |
用於抗病毒治療之2’-氟取代之碳-核苷類似物
|
DE102010045369A1
(de)
|
2010-09-14 |
2012-03-15 |
Merck Patent Gmbh |
Materialien für organische Elektrolumineszenzvorrichtungen
|
WO2012040124A1
(en)
|
2010-09-22 |
2012-03-29 |
Alios Biopharma, Inc. |
Azido nucleosides and nucleotide analogs
|
EA025341B1
(ru)
|
2010-09-22 |
2016-12-30 |
Алиос Биофарма, Инк. |
Замещенные аналоги нуклеотидов
|
US20120070411A1
(en)
|
2010-09-22 |
2012-03-22 |
Alios Biopharma, Inc. |
Substituted nucleotide analogs
|
WO2012068340A2
(en)
|
2010-11-18 |
2012-05-24 |
Opko Curna Llc |
Antagonat compositions and methods of use
|
US20150158909A1
(en)
|
2010-12-15 |
2015-06-11 |
Abbevie Inc. |
Anti-viral compounds
|
NZ613370A
(en)
|
2010-12-20 |
2015-05-29 |
Gilead Sciences Inc |
Combinations for treating hcv
|
WO2012088438A1
(en)
|
2010-12-22 |
2012-06-28 |
Eutropics Pharmaceuticals, Inc. |
Compositions and methods useful for treating diseases
|
WO2012088155A1
(en)
|
2010-12-22 |
2012-06-28 |
Alios Biopharma, Inc. |
Cyclic nucleotide analogs
|
WO2012092471A2
(en)
|
2010-12-29 |
2012-07-05 |
Development Center For Biotechnology |
Novel tubulin inhibitors and methods of using the same
|
CN103717222A
(zh)
|
2011-02-24 |
2014-04-09 |
浙江大学 |
桥二硫二氧代哌嗪及其在治疗癌症方面的用途
|
US9370528B2
(en)
|
2011-03-02 |
2016-06-21 |
Volant Holdings Gmbh |
Compositions, methods of treatment and diagnostics for treatment of hepatic steatosis alone or in combination with a hepatitis C virus infection
|
CN103502218B
(zh)
|
2011-03-04 |
2016-08-17 |
生命科技公司 |
用于缀合生物分子的化合物和方法
|
BR112013023681A2
(pt)
|
2011-03-16 |
2016-12-13 |
Hoffmann La Roche |
compostos de álcool propargílico 6,5-heterocíclico e uso dos mesmos
|
JP2012216832A
(ja)
|
2011-03-30 |
2012-11-08 |
Mitsubishi Chemicals Corp |
光電変換素子、太陽電池、太陽電池モジュール及びインク
|
CA2832818A1
(en)
|
2011-04-06 |
2012-10-11 |
The Trustees Of Princeton University |
Anti-viral combination therapy
|
KR20130138840A
(ko)
|
2011-04-13 |
2013-12-19 |
머크 샤프 앤드 돔 코포레이션 |
2''-치환된 뉴클레오시드 유도체 및 바이러스성 질환의 치료를 위한 그의 사용 방법
|
US8877733B2
(en)
|
2011-04-13 |
2014-11-04 |
Gilead Sciences, Inc. |
1′-substituted pyrimidine N-nucleoside analogs for antiviral treatment
|
WO2012142075A1
(en)
|
2011-04-13 |
2012-10-18 |
Merck Sharp & Dohme Corp. |
2'-azido substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseases
|
GB201108825D0
(en)
|
2011-05-25 |
2011-07-06 |
Univ Dundee |
Morpholino compounds, uses and methods
|
US20130018011A1
(en)
*
|
2011-06-10 |
2013-01-17 |
Hassan Javanbakht |
Method of treating dengue fever
|
KR20140064765A
(ko)
|
2011-06-30 |
2014-05-28 |
스텔라 에이피에스 |
Hcv 조합 치료
|
FR2977586B1
(fr)
|
2011-07-08 |
2013-07-12 |
Rhodia Operations |
Procede de fabrication de composes comprenant des fonctions nitriles
|
WO2013033270A2
(en)
|
2011-08-29 |
2013-03-07 |
Coferon, Inc. |
Bromodomain ligands capable of dimerizing in an aqueous solution, and methods of using same
|
BR112014005110A2
(pt)
|
2011-09-02 |
2017-04-18 |
Bayer Ip Gmbh |
pirimidinas aneladas substituídas e utilização das mesmas
|
CN102286047A
(zh)
|
2011-09-14 |
2011-12-21 |
郑州大学 |
2’-脱氧-2’-氟-4’-三氮唑取代-β-D胞苷类似物、其制备方法及其应用
|
US20130072528A1
(en)
|
2011-09-16 |
2013-03-21 |
Abbvie Inc. |
Methods for Treating HCV
|
DE202012013074U1
(de)
|
2011-09-16 |
2014-10-29 |
Gilead Pharmasset Lcc |
Zusammensetzungen zur Behandlung von HCV
|
WO2013044030A1
(en)
|
2011-09-23 |
2013-03-28 |
Enanta Pharmaceuticals, Inc. |
2'-chloroacetylenyl substituted nucleoside derivatives
|
MX2014004415A
(es)
|
2011-10-14 |
2015-06-05 |
Stc Unm |
Bicapas lipidicas soportadas por nanoparticulas porosas (protecelulas) para suministro dirigido, incluido el suministro transdermico de carga, y los metodos relacionados.
|
FR2982858B1
(fr)
|
2011-11-18 |
2013-11-29 |
Rhodia Operations |
Procede de fabrication de composes comprenant des fonctions nitriles
|
US20130244966A1
(en)
|
2011-12-12 |
2013-09-19 |
Catabasis Pharmaceuticals, Inc. |
Fatty acid antiviral conjugates and their uses
|
FR2984322B1
(fr)
|
2011-12-16 |
2013-12-20 |
Rhodia Operations |
Procede de fabrication de composes comprenant des fonctions nitriles
|
CA2860234A1
(en)
|
2011-12-22 |
2013-06-27 |
Alios Biopharma, Inc. |
Substituted phosphorothioate nucleotide analogs
|
US9073960B2
(en)
|
2011-12-22 |
2015-07-07 |
Alios Biopharma, Inc. |
Substituted nucleosides, nucleotides and analogs thereof
|
EP2797594A1
(en)
|
2011-12-28 |
2014-11-05 |
AbbVie Inc. |
Methods for treating hcv
|
CN102603836A
(zh)
|
2012-02-10 |
2012-07-25 |
郑州大学 |
五味子丙素简化物、类似物及其制备方法和应用
|
EA201791916A1
(ru)
|
2012-03-13 |
2018-07-31 |
Джилид Сайэнс, Инк. |
2'-замещенные карбануклеозидные аналоги для противовирусного лечения
|
TWI635111B
(zh)
|
2012-03-16 |
2018-09-11 |
馬克專利公司 |
共軛聚合物
|
US9441007B2
(en)
|
2012-03-21 |
2016-09-13 |
Alios Biopharma, Inc. |
Substituted nucleosides, nucleotides and analogs thereof
|
GEP201706721B
(en)
|
2012-03-21 |
2017-08-25 |
Alios Biopharma Inc |
Substituted nucleosides, nucleotides and analogs thereof
|
WO2013142124A1
(en)
|
2012-03-21 |
2013-09-26 |
Vertex Pharmaceuticals Incorporated |
Solid forms of a thiophosphoramidate nucleotide prodrug
|
WO2013142159A1
(en)
|
2012-03-21 |
2013-09-26 |
Alios Biopharma, Inc. |
Pharmaceutical combinations comprising a thionucleotide analog
|
NZ630805A
(en)
|
2012-03-22 |
2016-01-29 |
Alios Biopharma Inc |
Pharmaceutical combinations comprising a thionucleotide analog
|
WO2013147795A1
(en)
|
2012-03-29 |
2013-10-03 |
Empire Technology Development Llc |
Dioxaborinane co-polymers and uses thereof
|
US20150057243A1
(en)
|
2012-04-02 |
2015-02-26 |
Northern University |
Compositions and Methods for the Inhibition of Methyltransferases
|
JP2013237721A
(ja)
|
2012-05-11 |
2013-11-28 |
Nitto Denko Corp |
再剥離用水分散型アクリル系粘着剤組成物、及び粘着シート
|
EP2856531A1
(en)
|
2012-06-04 |
2015-04-08 |
Merck Patent GmbH |
Organic semiconductors
|
US9682970B2
(en)
|
2012-06-29 |
2017-06-20 |
Biotium, Inc. |
Fluorescent compounds and uses thereof
|
KR20150027155A
(ko)
|
2012-07-03 |
2015-03-11 |
브리스톨-마이어스 스큅 컴퍼니 |
바이러스 감염의 치료를 위한 뉴클레오시드 화합물의 부분입체이성질체적으로 풍부한 포스포르아미데이트 유도체의 제조 방법
|
EP2875015A1
(en)
|
2012-07-23 |
2015-05-27 |
Merck Patent GmbH |
Ligands and their preparation
|
US20140038991A1
(en)
|
2012-08-06 |
2014-02-06 |
Astar Biotech Llc |
Protein Kinase Inhibitors
|
EP2882750A4
(en)
|
2012-08-10 |
2016-08-17 |
Epizyme Inc |
INHIBITORS OF THE PROTEIN METHYLTRANSFERASE DOT1L AND METHOD OF USE THEREOF
|
WO2014031872A2
(en)
|
2012-08-23 |
2014-02-27 |
The Broad Institute, Inc. |
Small molecule inhibitors for treating parasitic infections
|
WO2014035140A2
(en)
|
2012-08-30 |
2014-03-06 |
Kainos Medicine, Inc. |
Compounds and compositions for modulating histone methyltransferase activity
|
EP2712868A1
(en)
|
2012-09-28 |
2014-04-02 |
B. Braun Melsungen AG |
5-Fluoruoracil Derivatives
|
MX353422B
(es)
|
2012-10-08 |
2018-01-12 |
Idenix Pharmaceuticals Llc |
Análogos de 2'-cloronucleósido para infección por vhc.
|
DE102012109685A1
(de)
|
2012-10-11 |
2014-04-17 |
Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. |
Verfahren zur Umwandlung reaktiver Gruppen an Si-C-gebundenen Resten von Silanen unter gleichzeitiger Vergrößerung von deren räumlichem Abstand zueinander
|
WO2014059901A1
(en)
|
2012-10-17 |
2014-04-24 |
Merck Sharp & Dohme Corp. |
2'-cyano substituted nucleoside derivatives and methods of use thereof for treatment of viral diseases
|
WO2014059902A1
(en)
|
2012-10-17 |
2014-04-24 |
Merck Sharp & Dohme Corp. |
2'-disubstituted substituted nucleoside derivatives and methods of use thereof for treatment of viral diseases
|
KR20120135501A
(ko)
|
2012-10-29 |
2012-12-14 |
에스에프씨 주식회사 |
축합환 화합물 및 이를 포함한 유기 발광 소자
|
EP2932317B1
(en)
|
2012-12-14 |
2024-02-21 |
Merck Patent GmbH |
Birefringent rm lens
|
WO2014100505A1
(en)
|
2012-12-21 |
2014-06-26 |
Alios Biopharma, Inc. |
Substituted nucleosides, nucleotides and analogs thereof
|
CA2894541A1
(en)
|
2012-12-21 |
2014-06-26 |
Alios Biopharma, Inc. |
Substituted nucleosides, nucleotides and analogs thereof
|
FR2999917B1
(fr)
|
2012-12-26 |
2017-06-23 |
Oreal |
Polymere a empreinte moleculaire pour pieger selectivement les molecules odorantes
|
US20140200215A1
(en)
|
2013-01-15 |
2014-07-17 |
Intermune, Inc. |
Lysophosphatidic acid receptor antagonists
|
JP6024479B2
(ja)
|
2013-01-28 |
2016-11-16 |
コニカミノルタ株式会社 |
光学フィルム、円偏光板および画像表示装置
|
WO2014124458A1
(en)
|
2013-02-11 |
2014-08-14 |
The Regents Of The University Of California |
Compositions and methods for treating neurodegenerative diseases
|
US9580400B2
(en)
|
2013-02-26 |
2017-02-28 |
Northeastern University |
Cannabinergic nitrate esters and related analogs
|
US20150065439A1
(en)
|
2013-02-28 |
2015-03-05 |
Vertex Pharmaceuticals Incorporated |
Pharmaceutical compositions
|
WO2014164533A1
(en)
|
2013-03-11 |
2014-10-09 |
Vertex Pharmaceuticals Incorporated |
Methods of stereoselective synthesis of substituted nucleoside analogs
|
US9790291B2
(en)
|
2013-03-14 |
2017-10-17 |
Formosa Plastics Corporation, Usa |
Non-phthalate compounds as electron donors for polyolefin catalysts
|
JP6329764B2
(ja)
|
2013-03-15 |
2018-05-23 |
信越化学工業株式会社 |
対称ハイパーブランチ型シリコーン変性重合性化合物、及びそのモジュール化した製造方法
|
US10138256B2
(en)
|
2013-03-15 |
2018-11-27 |
Celgene Car Llc |
MK2 inhibitors and uses thereof
|
CA2913206C
(en)
|
2013-06-26 |
2022-08-02 |
Alios Biopharma, Inc. |
Substituted nucleosides, nucleotides and analogs thereof
|
US10478445B2
(en)
|
2013-07-03 |
2019-11-19 |
Georgetown University |
Boronic acid derivatives of resveratrol for activating deacetylase enzymes
|
CN105473554B
(zh)
|
2013-07-10 |
2019-08-13 |
沃泰克斯药物股份有限公司 |
作为离子通道调节剂的稠合的哌啶酰胺类
|
CN104086612A
(zh)
|
2013-07-17 |
2014-10-08 |
郑州大学 |
4-取代胺基-2′-脱氧-2′-氟-4′-叠氮-β-D-胞苷类核苷化合物、制备方法及其应用
|
WO2015016187A1
(ja)
|
2013-07-29 |
2015-02-05 |
富士フイルム株式会社 |
非水二次電池用電解液および非水二次電池
|
EP3036102A4
(en)
|
2013-08-19 |
2017-01-25 |
Queen's University At Kingston |
Carbene functionalized composite materials
|
JP2016534124A
(ja)
|
2013-08-29 |
2016-11-04 |
ベイラー カレッジ オブ メディスンBaylor College Of Medicine |
代謝並びに体重関連疾患の処置のための組成物および方法
|
US10149859B2
(en)
|
2013-09-11 |
2018-12-11 |
Emory University |
Nucleotide and nucleoside therapeutic compositions and uses related thereto
|
US20160257657A1
(en)
|
2013-09-20 |
2016-09-08 |
University Of Pittsburgh - Of The Commonwealth System Of Higher Education |
Small molecule inhibitors of the nuclear translocation of androgen receptor for the treatment of castration-resistant prostate cancer
|
KR101628288B1
(ko)
|
2013-09-30 |
2016-06-08 |
주식회사 엘지화학 |
음성 광학 분산도를 갖는 광학 소자 제조용 조성물 및 이로부터 제조된 광학 이방체
|
EP3052511A4
(en)
|
2013-10-02 |
2017-05-31 |
Moderna Therapeutics, Inc. |
Polynucleotide molecules and uses thereof
|
TW201524990A
(zh)
|
2013-10-11 |
2015-07-01 |
Alios Biopharma Inc |
經取代之核苷、核苷酸及其類似物
|
CN105658219A
(zh)
|
2013-10-25 |
2016-06-08 |
艾伯维公司 |
用于治疗hcv的方法
|
UA119050C2
(uk)
|
2013-11-11 |
2019-04-25 |
Ґілеад Саєнсиз, Інк. |
ПІРОЛО[1.2-f][1.2.4]ТРИАЗИНИ, ЯКІ ВИКОРИСТОВУЮТЬСЯ ДЛЯ ЛІКУВАННЯ РЕСПІРАТОРНО-СИНЦИТІАЛЬНИХ ВІРУСНИХ ІНФЕКЦІЙ
|
US20150167017A1
(en)
|
2013-12-13 |
2015-06-18 |
Moderna Therapeutics, Inc. |
Alternative nucleic acid molecules and uses thereof
|
CN103709220B
(zh)
|
2014-01-13 |
2016-02-17 |
河南省科学院高新技术研究中心 |
3-甲基尿苷及4-甲基胞苷核苷类化合物、合成方法及其药物用途
|
EP2896678B1
(en)
|
2014-01-21 |
2018-10-17 |
Merck Patent GmbH |
Liquid crystal display
|
CN105979951B
(zh)
|
2014-02-06 |
2020-12-25 |
里博科学有限责任公司 |
作为流感rna复制的抑制剂的4’-二氟甲基取代的核苷衍生物
|
JP6144215B2
(ja)
|
2014-02-07 |
2017-06-07 |
富士フイルム株式会社 |
光電変換素子およびその使用方法、光センサ、並びに、撮像素子
|
CN105960608B
(zh)
|
2014-02-27 |
2018-06-15 |
Dic株式会社 |
液晶显示装置
|
EP2918658B1
(de)
|
2014-03-10 |
2020-05-13 |
Merck Patent GmbH |
Flüssigkristalline Medien mit homöotroper Ausrichtung
|
WO2015143712A1
(en)
|
2014-03-28 |
2015-10-01 |
Merck Sharp & Dohme Corp. |
4'-substituted nucleoside reverse transcriptase inhibitors
|
JP6517319B2
(ja)
|
2014-03-28 |
2019-05-22 |
キャリター・サイエンシーズ・リミテッド・ライアビリティ・カンパニーCalitor Sciences, Llc |
置換されたヘテロアリール化合物および使用方法
|
EP3131538B1
(en)
|
2014-04-15 |
2019-12-18 |
Nederlandse Organisatie voor toegepast- natuurwetenschappelijk onderzoek TNO |
New anti-clostridium compounds
|
US20170136132A1
(en)
|
2014-06-19 |
2017-05-18 |
Moderna Therapeutics, Inc. |
Alternative nucleic acid molecules and uses thereof
|
WO2015196128A2
(en)
|
2014-06-19 |
2015-12-23 |
Moderna Therapeutics, Inc. |
Alternative nucleic acid molecules and uses thereof
|
WO2015196130A2
(en)
|
2014-06-19 |
2015-12-23 |
Moderna Therapeutics, Inc. |
Alternative nucleic acid molecules and uses thereof
|
JP5880994B1
(ja)
|
2014-06-23 |
2016-03-09 |
Dic株式会社 |
重合性液晶組成物及び該組成物を用いて作製した光学異方体、位相差膜、位相差パターニング膜
|
CA2952966A1
(en)
|
2014-06-24 |
2015-12-30 |
Alios Biopharma, Inc. |
Substituted nucleosides, nucleotides and analogs thereof
|
JP6669675B2
(ja)
|
2014-06-24 |
2020-03-18 |
ヤンセン バイオファーマ インク. |
置換ヌクレオシド、ヌクレオチドおよびその類似体
|
KR20170081740A
(ko)
|
2014-07-15 |
2017-07-12 |
디아이씨 가부시끼가이샤 |
액정 표시 장치
|
TWI678369B
(zh)
|
2014-07-28 |
2019-12-01 |
美商基利科學股份有限公司 |
用於治療呼吸道合胞病毒感染之噻吩並[3,2-d]嘧啶、呋喃並[3,2-d]嘧啶及吡咯並[3,2-d]嘧啶化合物類
|
KR102289820B1
(ko)
|
2014-08-01 |
2021-08-17 |
삼성전자주식회사 |
축합환 화합물 및 이를 포함한 유기 발광 소자
|
US9920242B2
(en)
|
2014-08-22 |
2018-03-20 |
Arizona Board Of Regents On Behalf Of Arizona State University |
Metal-assisted delayed fluorescent materials as co-host materials for fluorescent OLEDs
|
EP3372655B1
(en)
|
2014-08-25 |
2019-12-18 |
Merck Patent GmbH |
Liquid-crystal medium
|
JP6326140B2
(ja)
|
2014-08-27 |
2018-05-16 |
富士フイルム株式会社 |
化合物、組成物、膜、光学機器
|
CN107108676A
(zh)
|
2014-09-15 |
2017-08-29 |
美迪维尔公司 |
用于制备非对映异构纯的磷酰胺酯前药的方法
|
WO2016066582A1
(en)
|
2014-10-28 |
2016-05-06 |
Bci Pharma |
Nucleoside kinase inhibitors
|
TWI698444B
(zh)
*
|
2014-10-29 |
2020-07-11 |
美商基利科學股份有限公司 |
製備核糖苷的方法
|
CN107108683A
(zh)
|
2014-10-31 |
2017-08-29 |
共晶制药股份有限公司 |
用于治疗黄病毒科病毒和癌症的2’,2’‑二卤代核苷类似物
|
US20170343847A1
(en)
|
2014-11-06 |
2017-11-30 |
Merck Patent Gmbh |
Light modulation element
|
KR20170082590A
(ko)
|
2014-11-11 |
2017-07-14 |
메르크 파텐트 게엠베하 |
바이메소젠성 화합물 및 메소젠성 매질
|
CN105646629A
(zh)
|
2014-11-25 |
2016-06-08 |
广州市恒诺康医药科技有限公司 |
L-核苷类化合物及其应用
|
CN105777580B
(zh)
|
2014-12-18 |
2018-05-18 |
湖南化工研究院有限公司 |
酰基乙腈类化合物及其制备方法与应用
|
JP2018501514A
(ja)
|
2014-12-19 |
2018-01-18 |
メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツングMerck Patent Gesellschaft mit beschraenkter Haftung |
光変調素子
|
MA41213A
(fr)
|
2014-12-19 |
2017-10-24 |
Alios Biopharma Inc |
Nucléosides substitués, nucléotides et analogues de ceux-ci
|
MA41441A
(fr)
|
2014-12-19 |
2017-12-12 |
Alios Biopharma Inc |
Nucléosides substitués, nucléotides et analogues de ceux-ci
|
EP3240859B1
(en)
|
2014-12-30 |
2018-10-24 |
Merck Patent GmbH |
Bimesogenic compounds and mesogenic media
|
WO2016115222A1
(en)
|
2015-01-14 |
2016-07-21 |
Riboscience Llc |
4'-azido substituted nucleoside derivatives as inhibitors of ebola virus rna replication
|
EP3247767B1
(de)
|
2015-01-20 |
2018-12-26 |
cynora GmbH |
Organische moleküle, insbesondere zur verwendung in optoelektronischen bauelementen
|
CN107109233A
(zh)
|
2015-01-20 |
2017-08-29 |
捷恩智株式会社 |
液晶组合物及液晶显示元件
|
EP3048159B1
(en)
|
2015-01-22 |
2019-08-07 |
Merck Patent GmbH |
Liquid crystal medium
|
WO2016116124A1
(en)
|
2015-01-23 |
2016-07-28 |
Merck Patent Gmbh |
Light modulation element
|
US20170357131A1
(en)
|
2015-01-23 |
2017-12-14 |
Merck Patent Gmbh |
Light modulation element
|
KR102539268B1
(ko)
|
2015-02-10 |
2023-06-07 |
메르크 파텐트 게엠베하 |
액정 매질
|
JP6485106B2
(ja)
|
2015-02-24 |
2019-03-20 |
Jnc株式会社 |
液晶組成物および液晶表示素子
|
WO2016145142A1
(en)
|
2015-03-10 |
2016-09-15 |
Emory University |
Nucleotide and nucleoside therapeutics compositions and uses related thereto
|
KR102587314B1
(ko)
|
2015-03-13 |
2023-10-12 |
메르크 파텐트 게엠베하 |
액정 매질
|
KR20160110900A
(ko)
|
2015-03-13 |
2016-09-22 |
메르크 파텐트 게엠베하 |
액정 매질
|
JP6325171B2
(ja)
|
2015-03-17 |
2018-05-16 |
富士フイルム株式会社 |
有機半導体組成物、及び、有機半導体素子の製造方法
|
WO2016152340A1
(ja)
|
2015-03-24 |
2016-09-29 |
Jnc株式会社 |
液晶組成物および液晶表示素子
|
WO2016161176A1
(en)
|
2015-04-01 |
2016-10-06 |
The California Institute For Biomedical Research |
Methods for treating viral infections
|
FR3034767A1
(fr)
|
2015-04-07 |
2016-10-14 |
Centre Nat Rech Scient |
Reduction des fonctions carbonyles de glucides et derives de glucides en milieu aqueux par le dithionite de sodium
|
JPWO2016170948A1
(ja)
|
2015-04-23 |
2018-02-15 |
Jnc株式会社 |
液晶組成物および液晶表示素子
|
WO2016172631A2
(en)
|
2015-04-24 |
2016-10-27 |
President And Fellows Of Harvard College |
Substrate selective inhibitors of insulin-degrading enzyme (ide) and uses thereof
|
CA2984421C
(en)
|
2015-05-01 |
2024-04-09 |
Cocrystal Pharma, Inc. |
Nucleoside analogs for treatment of the flaviviridae family of viruses and cancer
|
CN106279322B
(zh)
|
2015-05-15 |
2019-07-30 |
上海唐润医药科技有限公司 |
抗丙肝病毒的核苷类化合物及其应用
|
DE102015210388A1
(de)
|
2015-06-05 |
2016-12-08 |
Siemens Aktiengesellschaft |
Organische Heterozyklische Alkalimetallsalze als n-Dotierstoffe in der Organischen Elektronik
|
RU2018104310A
(ru)
|
2015-07-06 |
2019-08-06 |
Байер Кропсайенс Акциенгезельшафт |
Азотсодержащие гетероциклы в качестве пестицидов
|
WO2017019817A1
(en)
|
2015-07-29 |
2017-02-02 |
Medivation Technologies, Inc. |
Methods and compositions for targeted therapeutics
|
WO2017019830A1
(en)
|
2015-07-29 |
2017-02-02 |
Medivation Technologies, Inc. |
Methods and compositions for targeted therapeutics
|
WO2017019822A1
(en)
|
2015-07-29 |
2017-02-02 |
Medivation Technologies, Inc. |
Pellet composition containing repair cells
|
WO2017023894A1
(en)
|
2015-08-03 |
2017-02-09 |
Raze Therapeutics, Inc. |
Mthfd2 inhibitors and uses thereof
|
MX2018001073A
(es)
|
2015-08-06 |
2018-06-12 |
Chimerix Inc |
Nucleosidos de pirrolopirimidina y analogos de los mismos utiles como agentes antivirales.
|
MX2018001814A
(es)
|
2015-08-13 |
2018-05-07 |
Merck Sharp & Dohme |
Compuestos dinucleotidos ciclicos como agonistas del estimulador de genes de interferon.
|
TW202321249A
(zh)
|
2015-08-26 |
2023-06-01 |
比利時商健生藥品公司 |
使用作為prmt5抑制劑之新穎經6-6雙環芳香環取代之核苷類似物
|
KR20180051582A
(ko)
|
2015-09-09 |
2018-05-16 |
메르크 파텐트 게엠베하 |
액정 매질
|
CN106518766A
(zh)
|
2015-09-11 |
2017-03-22 |
中国人民解放军军事医学科学院毒物药物研究所 |
新型二芳基脲类化合物,其制备方法及其医药用途
|
CN106518767A
(zh)
|
2015-09-11 |
2017-03-22 |
中国人民解放军军事医学科学院毒物药物研究所 |
取代苯并吡唑二芳基脲类化合物,其制备方法及其医药用途
|
WO2017045740A1
(en)
|
2015-09-15 |
2017-03-23 |
Merck Patent Gmbh |
Liquid-crystalline media having homeotropic alignment
|
BR112018005048B8
(pt)
|
2015-09-16 |
2021-03-23 |
Gilead Sciences Inc |
uso de um composto antiviral ou sal do mesmo para o tratamento de uma infecção por coronaviridae
|
CN105254624B
(zh)
|
2015-09-18 |
2019-08-09 |
上海吉铠医药科技有限公司 |
异噻唑衍生物pim激酶抑制剂及其制备方法与在制药中的应用
|
CN105218523B
(zh)
|
2015-09-18 |
2019-08-23 |
上海吉铠医药科技有限公司 |
吡啶衍生物pim激酶抑制剂及其制备方法与在制药中的应用
|
CN105130959B
(zh)
|
2015-09-18 |
2018-08-03 |
上海吉铠医药科技有限公司 |
嘧啶衍生物pim激酶抑制剂及其制备方法与在制药中的应用
|
EP3356347A1
(en)
|
2015-09-28 |
2018-08-08 |
Araxes Pharma LLC |
Inhibitors of kras g12c mutant proteins
|
WO2017059357A1
(en)
|
2015-09-30 |
2017-04-06 |
Vertex Pharmaceuticals Incorporated |
Method for treating cancer using a combination of dna damaging agents and atr inhibitors
|
US11866754B2
(en)
|
2015-10-16 |
2024-01-09 |
Modernatx, Inc. |
Trinucleotide mRNA cap analogs
|
AU2016340183A1
(en)
|
2015-10-16 |
2018-04-19 |
Modernatx, Inc. |
mRNA cap analogs and methods of mRNA capping
|
EP4086269A1
(en)
|
2015-10-16 |
2022-11-09 |
ModernaTX, Inc. |
Mrna cap analogs with modified phosphate linkage
|
WO2017066791A1
(en)
|
2015-10-16 |
2017-04-20 |
Modernatx, Inc. |
Sugar substituted mrna cap analogs
|
WO2017066782A1
(en)
|
2015-10-16 |
2017-04-20 |
Modernatx, Inc. |
Hydrophobic mrna cap analogs
|
WO2017068875A1
(ja)
|
2015-10-23 |
2017-04-27 |
Jnc株式会社 |
液晶組成物および液晶表示素子
|
WO2017073932A1
(ko)
|
2015-10-26 |
2017-05-04 |
주식회사 엘지화학 |
아민 화합물 및 이를 포함하는 유기 발광 소자
|
WO2017073933A1
(ko)
|
2015-10-26 |
2017-05-04 |
주식회사 엘지화학 |
스피로형 화합물 및 이를 포함하는 유기 발광 소자
|
WO2017073931A1
(ko)
|
2015-10-28 |
2017-05-04 |
주식회사 엘지화학 |
스피로형 화합물 및 이를 포함하는 유기 발광 소자
|
EA201891235A1
(ru)
|
2015-11-25 |
2018-12-28 |
Дзе Риджентс Оф Дзе Юниверсити Оф Калифорния |
Составы лекарственных средств для лечения злокачественной опухоли
|
EP3383874A1
(de)
|
2015-12-03 |
2018-10-10 |
Bayer CropScience Aktiengesellschaft |
Mesolonische halogenierte 3-(acetyl)-1-[(1,3-thiazol-5-yl)methyl]-1h-imidazo[1,2-a]pyridin-4-ium-2-olat derivate und verwandte verbindungen als insektizide
|
CN108368424B
(zh)
|
2015-12-11 |
2022-06-03 |
默克专利股份有限公司 |
可聚合化合物及其在液晶显示器中的用途
|
CN106892920B
(zh)
|
2015-12-18 |
2019-12-13 |
中国医学科学院医药生物技术研究所 |
苦豆碱衍生物、其制备方法及用途
|
KR102419178B1
(ko)
|
2015-12-29 |
2022-07-11 |
삼성디스플레이 주식회사 |
유기 발광 소자
|
EP3426642A4
(en)
|
2016-03-09 |
2019-10-09 |
Janssen BioPharma, Inc. |
ACYCLIC ANTIVIRALS
|
WO2017153186A1
(en)
|
2016-03-10 |
2017-09-14 |
Janssen Pharmaceutica Nv |
Substituted nucleoside analogues for use as prmt5 inhibitors
|
ES2947636T3
(es)
|
2016-03-16 |
2023-08-14 |
Kura Oncology Inc |
Derivados de tieno[2,3-d]pirimidina sustituida como inhibidores de menina-MLL y métodos de uso
|
WO2017165489A1
(en)
|
2016-03-23 |
2017-09-28 |
Emory University |
Antiviral agents for treating zika and dengue virus infections
|
CN107286190A
(zh)
|
2016-04-13 |
2017-10-24 |
刘沛 |
核苷之烃氧基苄基氨基磷酸/膦酸酯衍生物的制备及其医药用途
|
WO2017184668A1
(en)
|
2016-04-20 |
2017-10-26 |
Gilead Sciences, Inc. |
Methods for treating flaviviridae virus infections
|
GB201609600D0
(en)
|
2016-06-01 |
2016-07-13 |
Nucuna Biomed Ltd |
Cancer treatments
|
US11840766B2
(en)
|
2016-06-01 |
2023-12-12 |
Queen's University At Kingston |
Etching metal using N-heterocyclic carbenes
|
JP2019527381A
(ja)
|
2016-07-20 |
2019-09-26 |
メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツングMerck Patent Gesellschaft mit beschraenkter Haftung |
光学スイッチ素子において使用するためのスイッチ層
|
US20190169221A1
(en)
|
2016-08-12 |
2019-06-06 |
Janssen Biopharma, Inc. |
Substituted nucleosides, nucleotides and analogs thereof
|
JP2018044028A
(ja)
|
2016-09-12 |
2018-03-22 |
オルガノサイエンス株式会社 |
液晶組成物
|
KR20230156818A
(ko)
|
2016-10-03 |
2023-11-14 |
시질론 테라퓨틱스, 인크. |
화합물, 장치, 및 이의 용도
|
KR20190059922A
(ko)
|
2016-10-05 |
2019-05-31 |
메르크 파텐트 게엠베하 |
유기 반도체성 화합물
|
WO2018098206A1
(en)
|
2016-11-23 |
2018-05-31 |
Cv6 Therapeutics (Ni) Limited |
Hydantoin containing deoxyuridine triphosphatase inhibitors
|
WO2018106818A1
(en)
|
2016-12-07 |
2018-06-14 |
Kura Oncology, Inc. |
Methods of promoting beta cell proliferation
|
WO2018106820A1
(en)
|
2016-12-07 |
2018-06-14 |
Kura Oncology, Inc. |
Methods of promoting beta cell proliferation
|
JP6551618B2
(ja)
|
2016-12-16 |
2019-07-31 |
Dic株式会社 |
表示素子用封止材料組成物、及び、それを用いた表示素子
|
WO2018116901A1
(ja)
|
2016-12-19 |
2018-06-28 |
Dic株式会社 |
重合性組成物、及び、それを用いた光学異方体
|
WO2018119263A1
(en)
|
2016-12-22 |
2018-06-28 |
Incyte Corporation |
Heterocyclic compounds derivatives as pd-l1 internalization inducers
|
US11492367B2
(en)
|
2017-01-27 |
2022-11-08 |
Janssen Biotech, Inc. |
Cyclic dinucleotides as sting agonists
|
US12089486B2
(en)
|
2017-02-08 |
2024-09-10 |
Universal Display Corporation |
Organic electroluminescent materials and devices
|
AU2018235754B2
(en)
*
|
2017-03-14 |
2021-04-08 |
Gilead Sciences, Inc. |
Methods of treating feline coronavirus infections
|
CN110691779B
(zh)
|
2017-03-24 |
2023-10-10 |
库拉肿瘤学公司 |
治疗血液系统恶性肿瘤和尤因肉瘤的方法
|
JP2020515559A
(ja)
|
2017-03-31 |
2020-05-28 |
ぺロトン セラピューティクス,インク. |
Cd73阻害剤とその使用
|
PL3611174T3
(pl)
|
2017-04-07 |
2022-08-08 |
Medshine Discovery Inc. |
Pochodne [1,2,4]triazolo[1,5-c]pirymidyny jako inhibitor receptora a2a
|
TW201902891A
(zh)
|
2017-04-13 |
2019-01-16 |
德商麥克專利有限公司 |
用於有機電子裝置之組成物
|
ES2938859T3
(es)
|
2017-05-01 |
2023-04-17 |
Gilead Sciences Inc |
Una forma cristalina de (S)-2-etilbutilo 2-(((S)-(((2R,3S,4R,5R)-5-(4-aminopirrolo[2,1-f][1,2,4]triazin-7-il)-5-ciano-3,4-dihidroxitetrahidrofuran-2-il)metoxi)(fenoxi)fosforil)amino)propanoato
|
US11466047B2
(en)
|
2017-05-12 |
2022-10-11 |
Merck Sharp & Dohme Llc |
Cyclic di-nucleotide compounds as sting agonists
|
US11666555B2
(en)
|
2017-05-17 |
2023-06-06 |
Drexel University |
RelA inhibitors for biofilm disruption
|
US10858301B2
(en)
|
2017-05-25 |
2020-12-08 |
The Scripps Research Institute |
Direct oxidation of olefins to oxygenated species
|
US10004719B1
(en)
|
2017-05-30 |
2018-06-26 |
Taigen Biotechnology Co., Ltd. |
Solid dispersion formulation
|
WO2018222172A1
(en)
|
2017-05-30 |
2018-12-06 |
Taigen Biotechnology Co., Ltd. |
Solid dispersion formulation
|
AU2018276305A1
(en)
|
2017-05-31 |
2019-12-19 |
Commonwealth Scientific And Industrial Research Organisation |
Inhibiting hydrocarbon hydrate agglomeration
|
US11542248B2
(en)
|
2017-06-08 |
2023-01-03 |
Kura Oncology, Inc. |
Methods and compositions for inhibiting the interaction of menin with MLL proteins
|
JP2018203945A
(ja)
|
2017-06-08 |
2018-12-27 |
Dic株式会社 |
重合性液晶組成物、及び、それを用いた光学異方体
|
CN111051281A
(zh)
|
2017-06-21 |
2020-04-21 |
波涛生命科学有限公司 |
用于合成的化合物、组合物和方法
|
CN111093627B
(zh)
|
2017-07-11 |
2024-03-08 |
吉利德科学公司 |
用于治疗病毒感染的包含rna聚合酶抑制剂和环糊精的组合物
|
US11548893B2
(en)
|
2017-07-15 |
2023-01-10 |
Arisan Therapeutics Inc. |
Enantiomerically pure adamantane carboxamides for the treatment of filovirus infection
|
PL3678668T3
(pl)
|
2017-09-08 |
2024-06-03 |
The Board Of Trustees Of The Leland Stanford Junior University |
Inhibitory enpp1 i ich zastosowanie w leczeniu nowotworu
|
EP3681889A1
(en)
|
2017-09-13 |
2020-07-22 |
Merck Patent GmbH |
Organic semiconducting compounds
|
CA3075950A1
(en)
|
2017-09-18 |
2019-03-21 |
Janssen Biopharma, Inc. |
Substituted nucleosides, nucleotides and analogs thereof
|
KR20190041918A
(ko)
|
2017-10-13 |
2019-04-23 |
메르크 파텐트 게엠베하 |
액정 매질
|
US20210177827A1
(en)
|
2017-10-25 |
2021-06-17 |
Children`S Medical Center Corporation |
Papd5 inhibitors and methods of use thereof
|
CN111315796B
(zh)
|
2017-11-02 |
2023-11-24 |
天光材料科技股份有限公司 |
有机半导体化合物
|
CN109748943A
(zh)
|
2017-11-03 |
2019-05-14 |
中国科学院上海药物研究所 |
2’-c-甲基取代核苷类化合物及其制备与用途
|
CN109748944B
(zh)
|
2017-11-03 |
2021-12-10 |
中国科学院上海药物研究所 |
5’-脱氧-5’-异丙基取代氨基核苷类化合物、其制备方法和用途
|
CN109748921B
(zh)
|
2017-11-03 |
2022-03-22 |
中国科学院上海药物研究所 |
N-叔丁氧羰基保护的杂环类化合物、其制备方法及其用于制备c-核苷类似物的方法
|
WO2019092171A1
(en)
|
2017-11-09 |
2019-05-16 |
Inflazome Limited |
Novel sulfonamide carboxamide compounds
|
JP7207321B2
(ja)
|
2017-11-16 |
2023-01-18 |
Jsr株式会社 |
レジスト下層膜形成用組成物、レジスト下層膜及びその形成方法、パターニングされた基板の製造方法並びに化合物
|
EP3502209B1
(en)
|
2017-12-20 |
2020-10-14 |
Merck Patent GmbH |
Liquid-crystalline media having homeotropic alignment
|
EP3502210B1
(en)
|
2017-12-20 |
2020-09-09 |
Merck Patent GmbH |
Liquid-crystal medium
|
EP3727401A4
(en)
|
2017-12-20 |
2022-04-06 |
Merck Sharp & Dohme Corp. |
CYCLIC DINUCLEOTIDE COMPOUNDS USED AS STING AGONISTS
|
KR20190076339A
(ko)
|
2017-12-22 |
2019-07-02 |
한미약품 주식회사 |
신규한 2,6-나프티리딘 2-옥시드 유도체 화합물 및 이의 용도
|
WO2019133712A1
(en)
|
2017-12-27 |
2019-07-04 |
Schinazi Raymond F |
Combined modalities for nucleosides and/or nadph oxidase (nox) inhibitors as myeloid-specific antiviral agents
|
WO2019129059A1
(zh)
|
2017-12-29 |
2019-07-04 |
上海和誉生物医药科技有限公司 |
一种具有cd73抑制活性的膦酸衍生物、其制备方法和应用
|
JP2019137753A
(ja)
|
2018-02-08 |
2019-08-22 |
シャープ株式会社 |
液晶組成物および液晶ディスプレイ
|
BR112020015743A2
(pt)
|
2018-02-08 |
2020-12-15 |
Enyo Pharma |
Derivados de tiofeno não fundido e seus usos
|
EP3761993A4
(en)
|
2018-03-09 |
2022-03-09 |
Arcus Biosciences, Inc. |
PARENTERAL IMMUNITY-BOOSTING DRUGS
|
CN108276352B
(zh)
|
2018-03-13 |
2022-09-20 |
华东理工大学 |
一种具有杀线虫活性的含氮杂环化合物及其制法和用途
|
WO2019195056A1
(en)
|
2018-04-04 |
2019-10-10 |
Sigilon Therapeutics, Inc. |
Methods, compositions, and implantable elements comprising stem cells
|
WO2019215076A1
(de)
|
2018-05-08 |
2019-11-14 |
Bayer Aktiengesellschaft |
Verfahren zur herstellung stickstoffhaltiger heterocyclen
|
CN108727344A
(zh)
|
2018-05-14 |
2018-11-02 |
嘉兴特科罗生物科技有限公司 |
一种化合物及其合成方法和应用
|
WO2020033413A2
(en)
|
2018-08-07 |
2020-02-13 |
Tosk, Inc. |
Modulators of ras gtpase
|
JP7025064B2
(ja)
|
2018-08-09 |
2022-02-24 |
ヤマサ醤油株式会社 |
4’-置換ヌクレオシド誘導体の立体選択的合成法
|
CN110215456A
(zh)
|
2019-06-25 |
2019-09-10 |
华中农业大学 |
一种由gc376与gs-441524组成的猫冠状病毒抑制剂组合物
|
CN110330540A
(zh)
|
2019-08-08 |
2019-10-15 |
木天(济南)生物科技有限公司 |
核苷盐及其制备方法
|
CN110724174B
(zh)
|
2019-09-10 |
2021-02-05 |
广州六顺生物科技股份有限公司 |
吡咯并三嗪类化合物、组合物及其应用
|
CN110776512A
(zh)
|
2019-11-28 |
2020-02-11 |
成都傲飞生物化学品有限责任公司 |
一种核苷类似物的制备方法
|
TWI791193B
(zh)
|
2020-02-18 |
2023-02-01 |
美商基利科學股份有限公司 |
抗病毒化合物
|
CN118598916A
(zh)
|
2020-02-18 |
2024-09-06 |
吉利德科学公司 |
抗病毒化合物
|
TW202245800A
(zh)
|
2020-02-18 |
2022-12-01 |
美商基利科學股份有限公司 |
抗病毒化合物
|
CN111620909B
(zh)
|
2020-06-05 |
2022-12-02 |
广东中科药物研究有限公司 |
一种瑞德西韦的前体药物及其制备方法与应用
|